Transforming Drug Discovery and Development:The Impact of Artificial Intelligence
Main Article Content
Abstract
Artificial intelligence (AI) is revolutionizing the drug development process, transforming the entire process. AI can help researchers find drug candidates faster, conduct clinical trials more efficiently, improve manufacturing processes, and expand market access options. It can speed up the first phases of drug discovery by facilitating quick screening of candidate compounds by anticipating interactions between molecules and target proteins. AI also plays a significant role in the successful repurposing of drugs by finding new therapeutic applications for medications approved for other purposes.Predictive toxicology is another area where AI is having a major impact. By predicting probable toxicities and side effects of drug candidates using AI, late-stage failures are reduced and patient safety ensured. AI is also reshaping trial methodology and patient recruiting in clinical trials, reducing costs and improving success rates.AI also helps the pharmaceutical industry deal with increasingly complicated regulatory environments by deciphering and analyzing regulatory documents and recommendations to ensure conformity with ever-changing norms. This capacity accelerates the regulatory approval process, allowing the introduction of new pharmaceuticals to the market.Despite the challenges, AI has had far-reaching and complex effects on the pharmaceutical industry. With the help of AI, the pharmaceutical industry can speed up the discovery of new drug ideas, improve the effectiveness of clinical trials, streamline production, and hone its approach to market access. The payoff for patients and the pharmaceutical business could be enormous.